Baylor College of Medicine-ko ikertzaileekin lankidetzan egindako argitalpenak (7)

2023

  1. Lung cancer risk discrimination of prediagnostic proteomics measurements compared with existing prediction tools

    Journal of the National Cancer Institute, Vol. 115, Núm. 9, pp. 1050-1059

2021

  1. Dietary advanced glycation end-products and colorectal cancer risk in the European prospective investigation into cancer and nutrition (EPIC) study

    Nutrients, Vol. 13, Núm. 9

  2. Dietary intake of advanced glycation end products (Ages) and mortality among individuals with colorectal cancer

    Nutrients, Vol. 13, Núm. 12

  3. Plasma concentrations of advanced glycation end-products and colorectal cancer risk in the EPIC study

    Carcinogenesis, Vol. 42, Núm. 5, pp. 705-713

  4. Soluble receptor for advanced glycation end-products (sRAGE) and colorectal cancer risk: A case-control study nested within a European prospective cohort

    Cancer Epidemiology Biomarkers and Prevention, Vol. 30, Núm. 1, pp. 182-192

2016

  1. A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease

    Science Translational Medicine, Vol. 8, Núm. 341

2010

  1. Pancreatic cancer risk and ABO blood group alleles: Results from the Pancreatic Cancer Cohort Consortium

    Cancer Research, Vol. 70, Núm. 3, pp. 1015-1023